Ceftolozane-tazobactam for the Treatment of Multi Drug-resistant Pseudomonas aeruginosa (MDRPA) Infections

BACKGROUND: Ceftolozane-tazobactam (TOL-TAZ) is a novel cephalosporin/β-lactamase inhibitor combination with potent activity against Pseudomonas aeruginosa, including MDRPA. TOL-TAZ use for MDRPA infections has not been well-studied. METHODS: We conducted a retrospective study to describe outcomes o...

Full description

Saved in:
Bibliographic Details
Published in:Open Forum Infect Dis
Main Authors: Molnar, Esther, Heil, Emily, Claeys, Kimberly, Hiles, Jon, Gallagher, Jason
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632154/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.643
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items